Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Holloway Michael Andrew received 15,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Holloway Michael Andrew (Director) received 15,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 40,000 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 15,000 shares
- Holding after
- 40,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Award | 15,000 | 40,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Holloway Michael Andrew
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Holloway Michael Andrew · Apr 17, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026